Omnicell Investor Presentation Deck
© 2023 Omnicell, Inc.
Omnicell, Inc.
Reconciliation of GAAP to Non-GAAP
(Unaudited, in thousands, except per share data and percentage)
Reconciliation of GAAP income (loss) from operations to non-GAAP income from operations:
GAAP income (loss) from operations
GAAP operating income (loss) % to total revenues
Share-based compensation expense
Amortization of acquired intangibles
Acquisition accounting impact related to deferred revenues
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities
Severance-related expenses
Non-GAAP income from operations
Non-GAAP operating margin (non-GAAP operating income as a % of total non-GAAP revenues)
Reconciliation of GAAP net income (loss) to non-GAAP net income:
GAAP net income (loss)
(a)
Share-based compensation expense
Amortization of acquired intangibles
Acquisition accounting impact related to deferred revenues
(a)
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities (a)
Severance-related expenses
Amortization of debt issuance costs
Tax effect of the adjustments above (b)
Non-GAAP net income
$
$
$
$
Three Months Ended March 31,
2023
2022
(22,963)
(7.9)%
(b) Tax effects calculated for all adjustments except share-based compensation expense, using an estimated annual effective tax rate of 21%
years 2023 and 2022.
4.6%
14,042
8,242
246
8,420
5,314
13,301
(15,000)
14,042
8,242
246
8,420
5,314
1,045
(4,886)
17,423
For the three months ended March 31, 2023, impairment charges of other assets were approximately $0.6 million related to property and equipment in
connection with restructuring activities for optimization of certain leased facilities.
both fiscal
$
$
$
$
1.6%
11.7%
5,084
16,208
9,053
378
1,395
1,753
3,527
37,398
8,213
16,208
9,053
378
1,395
1,753
3,527
1,038
(3,601)
37,964
23View entire presentation